ClinicalTrials.Veeva

Menu

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

Wyeth logo

Wyeth

Status

Completed

Conditions

Hemophilia B

Study type

Observational

Funder types

Industry

Identifiers

NCT00167973
3090A-101039

Details and patient eligibility

About

This is an open-label multi-center Registry in patients with hemophilia B receiving BeneFIX. All patients who begin treatment with BeneFIX in European Union countries, will be eligible for participation. Patient demographics will be collected at baseline for all patients. A baseline FIX activity and Bethesda assay for inhibitor based on historical data should be recorded if available. Adverse events as defined in the protocol will also be reported on the appropriate forms. Data will be collected from patients on an ongoing basis to ensure that information is being captured for each patient being treated with BeneFIX.

Enrollment

218 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with Hemophilia B scheduled to begin treatment with BeneFIX are eligible for Registry enrollment

Exclusion Criteria:

Trial contacts and locations

91

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems